Dr. Rajan George is the Founder, President and Chief Scientific Officer of Akshaya Bio Inc., a biotechnology company developing vaccines as well as other biotherapeutic agents.

Previously, Dr. George was Executive Vice President and Chief Technology Officer of Paladin Biosciences, a division of Paladin Labs Inc. (TSX:PLB), Edmonton, Alberta, Canada. He holds Adjunct Faculty appointment in the Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. The focus is on the development of therapeutic vaccines for chronic viral infections such as Hepatitis B and Hepatitis C.

Dr. George is the co-inventor of Chimigen® Vaccine Platform technology which received the Alberta Science and Technology award for innovation in 2004. He was the recipient of a Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation in 2009. Dr. George was Senior Vice President of Research and Development and a founding member of ViRexx Medical Corp., (TSX:VIR, AMEX:REX), Edmonton, Alberta, Canada, before Paladin acquisition.

Previously, a Research Scientist at the Glaxo Heritage Research Institute, University of Alberta, Edmonton, Canada, where the field of research was Hepatitis B virology and antiviral therapy. Dr. George received a Ph.D in Biochemistry from the Indian Institute of Sciences (Bangalore, India). He also had postdoctoral training at the University of Wisconsin in Madison, WI, USA and the University of Alberta (Edmonton, Alberta, Canada).